David Mitchell
Impact in
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
-
- Liver physiology and pathology
Papers in
-
- RNA and protein synthesis mechanisms 8
- RNA modifications and cancer 8
- RNA Research and Splicing 4
-
- Pharmacogenetics and Drug Metabolism 5
- Drug-Induced Hepatotoxicity and Protection 3
- Co-authors
- Daniel Acosta (7 shared papers)Kenneth S. Santone (3 shared papers)Sarah M. Assmann (3 shared papers)Philip C. Bevilacqua (4 shared papers)James V. Bruckner (2 shared papers)Rick Russell (3 shared papers)Elsie M. B. Sorensen (2 shared papers)Kenneth S. Ramos (1 shared paper)
- Journals
- RNA (3 papers)The Journal of Laryngology & Otology (2 papers)Journal of Molecular Biology (2 papers)Methods in enzymology on CD-ROM/Methods in enzymology (1 paper)Biochemical Pharmacology (1 paper)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
David Mitchell
19 papers receiving 699 citations
Peers
Comparison fields: 5 of 89
- Pharmacology 129
- Hepatology 43
- Molecular Biology 352
- Toxicology 17
- Speech and Hearing 28
Countries citing papers authored by David Mitchell
This map shows the geographic impact of David Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Mitchell more than expected).
Fields of papers citing papers by David Mitchell
This network shows the impact of papers produced by David Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Mitchell. The network helps show where David Mitchell may publish in the future.
Co-authors
The 25 scholars most cited alongside David Mitchell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1980 | 206 | |
| 2 | 1985 | 92 | |
| 3 | 2019 | 61 | |
| 4 | 1985 | 49 | |
| 5 | 1987 | 37 | |
| 6 | 2017 | 37 | |
| 7 | 2018 | 36 | |
| 8 | 1981 | 30 | |
| 9 | 1981 | 29 | |
| 10 | 1999 | 28 | |
| 11 | 2023 | 23 | |
| 12 | 2009 | 21 | |
| 13 | 2013 | 19 | |
| 14 | 1987 | 17 | |
| 15 | 2014 | 15 | |
| 16 | 1979 | 11 | |
| 17 | 1994 | 6 | |
| 18 | 1982 | 4 | |
| 19 | 2016 | 2 | |
| 20 | 1996 | 0 |
About David Mitchell
David Mitchell is a scholar working on Molecular Biology, Pharmacology, Hepatology, Genetics and Cancer Research, having authored 20 papers that have together received 723 indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (8 papers), RNA modifications and cancer (8 papers), Pharmacogenetics and Drug Metabolism (5 papers), RNA Research and Splicing (4 papers), Liver physiology and pathology (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Carcinogens and Genotoxicity Assessment (2 papers) and Amino Acid Enzymes and Metabolism (1 paper). The work is most often cited by research in Pharmacology (129 citations), Hepatology (43 citations), Molecular Biology (352 citations), Toxicology (17 citations) and Speech and Hearing (28 citations). David Mitchell has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Daniel Acosta, Kenneth S. Santone, Sarah M. Assmann, Philip C. Bevilacqua, James V. Bruckner, Rick Russell, Elsie M. B. Sorensen, Kenneth S. Ramos, David C. Anuforo and Mary Ann Lila Smith. Their work appears in journals such as RNA, The Journal of Laryngology & Otology, Journal of Molecular Biology, Methods in enzymology on CD-ROM/Methods in enzymology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.